WANY
IMGN

Wealthspire Advisors (New York)’s Immunogen Inc IMGN Stock Holding History

Wealthspire Advisors (New York)’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-17
Closed – – 851
2018
Q4 		$0 Buy
+17
New +$103 ﹤0.01% 930

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wealthspire Advisors (New York)'s IMGN Position: Q1 2019 in Review

Wealthspire Advisors (New York) sold out of Immunogen Inc (IMGN) in Q1 2019, closing a stake of 17 shares.

Wealthspire Advisors (New York) first reported a position in IMGN in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 212 funds tracked by Wall St. Rank hold IMGN as of Q1 2019.

  • Wealthspire Advisors (New York) reported no remaining Immunogen Inc position as of Q1 2019 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 17 Immunogen Inc shares in Q1 2019.
  • Wealthspire Advisors (New York) first reported a position in Immunogen Inc in Q4 2018 and held it in 1 quarter.
  • Wealthspire Advisors (New York)'s Immunogen Inc position peaked at $0 in Q4 2018.
  • 212 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2019.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2019, filed 8 May 2019.